Articles |
Correspondence to Dr A.F.H. Stalenhoef, Department of Medicine, Division of General Internal Medicine, University Hospital Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands.
Key Words: meeting summary European Lipoproteins Club
| Introduction |
|---|
Dr John Wetterau of Bristol-Myers Squibb Pharmaceutical Research Institute opened the meeting with a State of the Art Lecture entitled "The Microsomal Triglyceride Transfer Protein: Characterization and Role in the Assembly of VLDL and Chylomicrons." The microsomal triglyceride transfer protein (MTP) is a soluble lipid transfer protein found in the lumen of microsomes of liver and intestine. This heterodimer is composed of the multifunctional protein disulfide isomerase and a unique large subunit of molecular weight 97 000. In vitro, MTP catalyzes the transport of triglyceride, cholesteryl ester, and a variety of phospholipids between membranes. When one compares the fractional transfer rates, MTP appears to selectively bind and transport hydrophobic neutral lipid. However, the assays used to characterize MTP have at least 100-fold more phospholipid than neutral lipid, so in these assays, MTP actually transports more phospholipid than neutral lipid.
Abetalipoproteinemia is an autosomal recessive disease in which the subjects have a defect in the assembly and secretion of VLDL and chylomicrons. Recent studies by Dr Wetterau of abetalipoproteinemic subjects showed that MTP activity and the unique large subunit were absent in all four unrelated subjects studied. Frame shift, nonsense, and point mutations that explain the absence of MTP were found in these four subjects. These studies indicated that an absence of MTP function causes abetalipoproteinemia and that MTP is required for the assembly of apoBcontaining lipoproteins.
Hela
This article has been cited by other articles:
![]() |
D. L. Sprecher, B. V. Harris, E. A. Stein, P. S. Bellet, L. M. Keilson, and L. A. Simbartl Higher Triglycerides, Lower High-Density Lipoprotein Cholesterol, and Higher Systolic Blood Pressure in Lipoprotein Lipase–Deficient Heterozygotes: A Preliminary Report Circulation, December 15, 1996; 94(12): 3239 - 3245. [Abstract] [Full Text] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |